The number of diagnosed prevalent cases of heart failure is expected to experience an annual growth rate of 1.68 percent, increasing from 13.76 million in 2022 to reach 16.07 million by 2032. The report by GlobalData, a leading data and analytics company, showed that the rise will particularly be seen in the seven major markets — the US, France, Germany, Italy, Spain, the UK, and Japan.
Adults ages 60 years and above accounted for almost 85 percent of the diagnosed prevalent cases of heart failure in the seven countries while those in younger adults ages 19-59 years accounted for almost 14 percent of the cases. Children aged 18 years and younger accounted for 0.37 percent of the cases. This is apparent from GlobalData estimates for age-specific diagnosed prevalent cases.
Heart Failure with Preserved Ejection Fraction Dominates Diagnosed Cases
Heart failure with preserved ejection fraction — a form of heart failure — accounted for approximately 47 percent of the diagnosed prevalent cases of heart failure in the seven countries in 2022. “There is an increased need for individualization of in-hospital management, including treatments targeting the causative factors, and continuation of treatment after hospital discharge to improve long-term outcomes especially for acute heart failure,” Bhattacharya said.
“The case mix of heart failure is evolving, more epidemiological data on acute heart failure can improve the treatment outcomes. With early diagnosis and lifestyle modifications, more people with heart failure can perform well. “With respect to heart failure treatment, awareness among physicians, and obtaining the optimal management of heart failure patients while preventing underutilization, or suboptimal dosing of guideline-directed medical therapy is necessary for improving functional status, quality of life, and survival in patients with heart failure,” she added.
Source: IANS
